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LAY ABSTRACT
The aim of this study was to identify profiles of patients 
who are at risk of dropping out from biopsychosocial ap-
proaches to chronic pain management. A total of 575 pa-
tients were included in the study. Of these, 203 patients 
were randomized into 4 treatment groups: self-hypnosis /
self-care; music/self-care; self-care; psychoeduca-
tion/cognitive behavioural therapy. The remaining 372 
patients were not randomized, as they presented with the 
demand to learn self-hypnosis/self-care, and hence formed 
a “self-hypnosis/self-care demanders” group. Analyses 
of socio-demographics and behavioural data were con-
ducted, comparing early drop-outs (never attended treat-
ment), late drop-outs (6/9 sessions’ treatment) and con-
tinuers. Results showed that having an intermediate or 
high educational level protects against dropping out early 
or late in the management process. Having to wait for 
more than 4 months before starting the treatment, and 
being randomized, increases the risk of never starting it. 
Thus, in a context in which randomization is considered 
as a “gold standard” in evidence-based practice, these 
results indicate that this very principle could be delete-
rious to pain management in patients with chronic pain.
Objective: To identify profiles of patients who are 
at risk of dropping out from biopsychosocial ap-
proaches to chronic pain management.
Patients: A total of 575 patients were included in the 
study. Of these, 203 were randomized into 4 treat-
ment groups: self-hypnosis/self-care; music/self- 
care; self-care; and psychoeducation/cognitive 
behav ioural therapy. The remaining 372 patients were 
not randomized, as they presented with the demand 
to learn self-hypnosis/self-care, and therefore were 
termed a “self-hypnosis/self-care demanders” group.
Methods: Socio-demographics and behavioural data 
were included in the analyses. Univariates analyses, 
comparing early drop-outs (never attended treat-
ment), late drop-outs (6/9 sessions’ treatment) and 
continuers were conducted in order to select vari-
ables to include in a multivariate logistic regression. 
Results: Univariate analyses yielded 8 variables, out 
of 18 potential predictors for drop-out, which were 
eligible for inclusion in the multivariate logistic reg-
ression. The model showed that having an inter-
mediate or high educational level protects against 
dropping out early or late in the pain management 
process. Having to wait for more than 4 months 
before starting the treatment increases the risk of 
never starting it. Being randomized increases the 
risk of never starting the treatment.
Conclusion: In a context in which randomization 
is considered a “gold standard” in evidence-based 
practice, these results indicate that this very princi-
ple could be deleterious to pain management in pa-
tients with chronic pain.
Key words: chronic pain; non-pharmacological treatment; 
randomization; drop-out; loss to follow-up; attrition.
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Chronic pain is a complex disorder in which pain appears persistent and prolonged (>  3 months) 
and includes biological, psychological and socio-
professional factors that undermine patients’ everyday 
life. Patients and healthcare providers are increasingly 
turning to non-pharmacological treatments, such as 
hypnosis and music therapy, combined with cognitive 
behavioural therapy (CBT) (1). The efficacy of these 
treatment in managing chronic pain has been demon-
strated (2–4).
A major problem in clinical research is drop-out, which 
ranges from 5% to 46%, in chronic pain management, 
depending on the study (5). The first issue concerns the 
definition of drop-out, since this varies between authors: 
some regard drop-out as patients ending therapy before 
the agreed-end-of-treatment (6), others consider it as not 
attending therapy sessions even though patients have 
agreed to attend (7). The second issue is that few clinical 
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account, thus generating a bias in the overall results of 
clinical trials investigating the efficacy of such treatments 
(8). The lack of studies and the disagreement regarding 
definitions lead to a range of results in the study of 
drop-out predictors in chronic pain. Some authors have 
highlighted that a low educational level increases the risk 
of dropping out from therapy (cohort study (9)), while 
others have shown the contrary (randomized trial (10)). 
The same controversy can be seen when considering age, 
sex and personality (systematic review (5); randomized 
trial (10); retrospective study (11); non-randomized trial 
(12)). Predictors outside of patient-related factors have 
mostly been studied in the mental health literature. As the 
management of chronic pain and mental health is relativ-
ely similar, consideration of these factors seems relevant. 
A meta-analysis showed that, in psychotherapy settings, 
the therapist expertise had an influence on drop-out. 
The results demonstrated that when trainees (pre-degree 
attainment) lead the group therapy, patients tended to 
be more likely to drop-out (13). Another meta-analysis 
showed that patients’ motivational level predicted 
drop-out from psychotherapy (14). A further barrier to 
completing treatments is the waiting period between 
initial contact and the effective start of the treatment 
(retrospective study (15)). Another retrospective study 
highlighted that the longer the patients in a substance 
abuse treatment programme had to wait until the onset 
of treatment (≥8 days), the more likely they were not to 
attend the first session of the programme (16). 
Given the lack of consensus, a better understanding 
of the profile of drop-outs and contextual risk factors, is 
essential in order to prevent this phenomenon, enhance 
treatment adherence and, consequently, ameliorate the 
study of treatment efficacy in chronic pain. 
The aim of this study was to retrospectively identify 
patient- and context-related factors to explain drop-out 




A total of 607 patients with chronic pain who spontaneously at-
tended the Interdisciplinary Algology Department of the University 
Hospital of Liège, Belgium, from March 2015 until December 
2017, were recruited to the study. A final total of 575 patients were 
included in the study (7 patients were not interested in the study, 
23 did not complete the T1 questionnaires, one had other health 
issues, and one could not attend therapy due to organizational is-
sues). Inclusion criteria were: patients at least 18 years old; fluent 
in French; and a diagnosis of chronic pain. Exclusion criteria were: 
psychiatric disorders (schizophrenia, psychosis, borderline with 
prolonged dissociation episode); drug addiction; and alcoholism. 
A proportion of patients were randomized into 4 treatment groups: 
psychoeducation/cognitive behavioural therapy (CBT), self-care, 
self-hypnosis combined with self-care; and specifically composed 
music combined with self-care. Other patients presented with the 
specific demand to learn self-hypnosis/self-care, and thus were 
not randomized; they were included in a “self-hypnosis/self-care 
demanders group”. Drop-out was divided into 2 categories: “early 
drop-outs”: patients who agreed to participate, but never attended 
the treatment groups; and “late drop-outs”: patients who attended 
fewer than 6 sessions out of 9. Continuers were patients who 
completed the treatment programme. 
The study was approved by the ethics committee of the Medical 
School of the University of Liège. All participants provided 
written informed consent to participate in the study. 
Design
This study is part of a randomized clinical trial, registered 
retrospectively on ClinicalTrials.gov (NCT04218227) on the 
1 March 2020. 
The study procedure comprised the following phases: 
• Screening phase, in which medical doctor specialized in pain 
management (i.e. algologist) made a pain diagnosis and the 
multidisciplinary team approach was proposed.
• Baseline pre-treatment examination of patients’ health char-
acteristics with questionnaires.
• Randomization into treatment groups.
• Treatment phase.
• Post-treatment assessment using the same questionnaires as 
in the pre-treatment phase. 
• Follow-up sessions at 6 and 12 months after the end of the 
treatments, in which patients were asked to complete the 
same questionnaires.
Treatment groups
The treatments have been described previously by Vanhau-
denhuyse et al. (2). Each of the 4 treatment groups included 8 
patients, and each treatment comprised 7 sessions (1 per month) 
of 2 h and 2 follow-up sessions. 
Psychoeducation/CBT group. This treatment group was run by 
2 psychologists (NM and IS), and comprised group discussions, 
aimed at enhancing the patients’ autonomy, informing them and 
empowering them to become more active in their treatment. 
The psychologists gave a presentation on problems underlying 
chronic pain, on the biopsychosocial approach and the benefit 
of patients’ empowerment. Sessions included discussions on 
themes such as: specificities of chronic pain, psychological 
factors linked to it, attitudes and beliefs, and suggestions for 
coping with chronic pain. 
Self-care group. This treatment group was run by 3 psychologists 
(NM, IS and AV) and an algologist (M-EF), and was based on 
CBT. The principle was to teach patients to take care of them-
selves in their everyday life through concrete tasks. The objectives 
were to empower the patients and to reactivate and amplify their 
awareness of the positive experiences they encountered every 
day. All of the proposed tasks focused on the patient’s general 
well-being rather than on pain. Patients were asked to keep a 
daily journal in which they had to write down the tasks performed 
and their observations from each task. Each session began with a 
discussion of the tasks prescribed and completed.
Self-hypnosis/self-care group. This treatment group was run by 
psychologists (NM, IS, AV) and an algologist (M-EF), all of 
whom were specialized in clinical hypnosis. Self-care learning 
was the same as described above. At the end of each session, a 
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compact discs (CDs) containing the hypnosis exercise from the 
session, and were invited to perform the exercise on a daily basis. 
Six different exercises were proposed to patients, plus 2 more 
during the follow-up period. The first session was an introduc-
tion to hypnosis, and no exercise was realized. The first exercise 
included suggestions about relaxation, positive body sensations 
and invitation to observe a sunrise and a beautiful landscape, while 
relaxing in a white cloud chair. The second exercise was a safe 
place suggestions-based hypnotic script. The third exercise was 
centred on healing sleep suggestions. The 2 subsequent exercises 
were centred on analgesia suggestions. The final exercise was 
centred on hand analgesia suggestions. The 2 follow-up exercises 
were centred on lightness sensations and the metaphorical creation 
of a problem encountered in the patient’s life. All exercises were 
created by one of the co-authors (M-EF). The goal of listening to 
the CDs was to help the patients to self-induce hypnosis. 
Specially composed music/self-care group. This treatment group 
was run by psychologists (NM, IS, and AV) and an algologist 
(M-EF). The aim and the procedure were the same as in the 
“self-hypnosis/self-care” group above, except no hypnosis 
exercise was given. Instead, at the end of each session, patients 
were invited to listen to a specially composed melody for 20 
min. Six CDs were given to each patient and they were asked to 
listen to them on a daily basis, 2 more CDs were given during 
follow-up sessions. The music was composed and recorded by 
one co-author, who is specialized in music therapy (AC). 
Self-hypnosis/self-care demanders group. Finally, the “self-
hypnosis/self-care demanders” group received the same inter-
vention as the self-hypnosis/self-care group.
Data collection
Baseline data collection was performed based on the Initiative 
in Methods, Measurements and Pain Assessment in Clinical 
Trials (IMMPACT) recommendations (17): 
• General data were collected: patients medical and sociodemo-
graphic data, such as sex, age, educational level (i.e. highest 
qualification obtained), occupational status, diagnosis, and 
pain duration. It was also recorded whether patients were 
part of the agreement between the Interdisciplinary Algology 
Department and the National Institute for Health and Disability 
Insurance of Belgium (NIHDI) (termed “convention” in this 
study). This agreement permitted a predetermined number of 
patients with chronic pain to receive a multidisciplinary pain 
diagnosis and an adapted treatment programme, while the cost 
of clinical workup and treatments were directly reimbursed 
to the Interdisciplinary Algology Department by the NIHDI.
• Data on therapists’ expertise, randomization or no randomiza-
tion, and delay in onset of treatment were collected via the 
patients medical record. 
• Numerical rating scales (NRS) were used to assess pain and 
fatigue intensity, as subjectively perceived by the patients, on 
a scale ranging from 0 (no pain/fatigue) to 10 (pain/fatigue 
as intense as you could imagine) (18, 19). 
•  Hospital Anxiety and Depression Scale (HADS) was used to 
determine the levels of anxiety and depression subjectively 
perceived by patients. HADS is a 14-item self-report screen-
ing and contains 2 7-item subscales: anxiety and depression 
with a total score for each ranging from 0 to 21; the higher 
the score, the higher the symptoms (20).
• Insomnia Severity Index (ISI) was administered in order to 
measure insomnia related-difficulties. The index compris-
es 7 items that examine the severity of sleep-onset, sleep 
maintenance, satisfaction with current sleep, interference of 
sleep difficulties with daily functioning, and noticeability of 
impairment due to sleep alterations (21).
• Pain Disability Index (PDI) was used to assess the repercus-
sions of the interference of pain in the patients’ ability to 
engage in various activities. This is a self-reported scale in 
which the patient is asked to rate on scale from 0 to 10 the 
extent of disability in a target activity. PDI contains 7 cate-
gories of life activities, such as family/home, responsibility, 
recreation, social activity, occupation, sexual behaviour, 
self-care and life support activity. The higher the score, the 
higher the perceived disability (22).
• The Multidimensional Health Locus of Control Scale 
(MHLC) was used to measure the type of locus patients had. 
The scale is divided into 3 sub-scales (23): 
• Internal Health Locus of Control (IHLC): a high score on 
this subscale means that one attributes health problems as 
a consequence of one’s behaviours. 
• Powerful Other Health Locus of Control (PHLC): external 
locus of control. A high score on this subscale means that 
one will allocate one’s health problems to an external person.
• The Chance Health Locus of Control (CHCL): external 
locus of control, with assignation to chance. 
• The Survey of Pain Attitude-35 (SOPA-35) allows us to un-
derstand the attitudes and beliefs endorsed by patients with 
chronic pain. This scale comprises 7 subscales (24): 
• Harm: belief that hurt means physical injury.
• Disability: belief that one is disabled by pain.
• Medication: belief that the best treatment is medication.
• Solicitude: belief that it is the other’s responsibility to as-
sist one with the pain.
• Emotion: belief that emotions influence the pain expe-
rience.
• Medical cure: belief that it is the doctor’s duty to relieve 
one’s pain. 
• Control: amount of control the patients believe they have 
over the pain experience.
There is no total score, but a specific score for each subscale; 
the higher the score, the more the patient endorses the belief.
• The Short Form-36 (SF-36) assesses global quality of life. It is 
a 36-item scale that comprises 8 subscales from which 2 sum-
mary scores emerge: mental (MCS) and physical (PCS). The 
higher the score, the better the mental/physical quality (25).
French validation was used for all questionnaires except the 
SOPA-35.
Statistical analyses
Qualitative variables are represented as count and percentage. 
Quantitative variables with a normal distribution are represent-
ed as mean and standard deviation (SD), and as median and 
interquartile range (Q1–Q3) when symmetrical distribution 
is not fulfilled. The normality of the quantitative variable was 
investigated graphically and numerically. Univariate analyses 
were performed to compare variables between continuers and 
drop-out groups: χ2 test for categorical variables and one-way 
analysis of variance (ANOVA) or its non-parametric equivalent 
Kruskal–Wallis test for quantitative variables. Significant vari-
ables in univariate case were included in a multivariate logistic 
regression to produce a profile of patients at risk of dropping 
out. The dependent variable was the drop-out factor and the 
continuers were taken as the referential category. Two-tailed 
p-values < 0.05 were considered to be statistically significant. 
The acquired data were processed using statistical data process-
ing software R 3.6.0 (26).
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RESULTS
A total of 575 patients were included in this study. Of 
these, 281 (48.8%) were classified as drop-outs and 294 
(51.2%) as continuers. In the drop-out group (n=281), 
73 (26%) patients were considered “early drop-outs” as 
they had agreed to start treatments, but never attended 
to the sessions; and 208 (74%) were considered “late 
drop-outs” as they attended fewer than 6 sessions out 
of 9. There were no statistical differences in age, sex, 
occupational status, convention and aetiologies (Table 
I). Significant differences were found in educational 
levels: 4.5% of the continuers had a low educational 
level vs 10.9% for the early drop-outs and 13% for the 
late drop-outs (p = 0.002). The therapist’s expertise was 
significantly different: patients tended to continue ac-
cording to the therapist’s expertise (therapist one was 
considered to have the most expertise, while therapists 
2, 3 and 4 had less expertise): therapist one (28 years 
of group expertise) had 59.9% of continuers, 9% of 
early drop-outs and 31.1% of late drop-outs; therapist 2 
(25 years of group expertise) had 45.2% of continuers, 
15.4% of early drop-outs and 39.4% of late drop-outs. 
Therapist 3 (15 years of expertise) had 48% of con-
tinuers, 17.1% of early drop-outs and 34.9% of late 
drop-outs; therapist 4 (6 years of expertise) had 47.9% 
of continuers, 9.3% of early drop-outs and 42.8% of 
late drop-outs (p = 0.04). Randomization had an effect 
on the proportion of drop-outs: in the non-randomized 
group 72.1% were continuers vs 19.7% continuers in 
the randomized group (p < 0.001). The delay in onset 
of treatment was significantly different across groups: 
2.94 (1.76) months for continuers, 4.08 (2.15) for early 
drop-outs and 3.14 (2) for late drop-outs (p < 0.001).
Univariate analyses for behavioural variables
No statistical differences between continuers and all 
types of drop-outs were found for pain intensity, the 
subscale depression of the HADS, ISI, PDI, CHLC, 
Table I. Characteristics of continuers and drop-outs in a chronic pain treatment programme. Early drop-outs: patients who never started 
the treatments; late drop-outs: patients who attended to < 6 sessions out of 9; continuers: patients who completed the treatments




(n = 208) p-value





  60 (20.4)
65 (89)
  8 (10.9)
170 (81.7)
  38 (18.3)
0.17
Education, n (%)
  Low (≤6 years)
  Intermediate (12 years)
  High (≥15 years)
  Missing data
  13 (4.4)
191 (64.9)
  86 (29.3)
    4 (1.4)
  8 (10.9)
36 (49.3)
26 (35.6)
  3 (4.2)
  27 (13)
129 (62.1)
  49 (23.5)
    3 (1.4)
0.002*





  Missing data
  79 (26.8)
148 (50.3)
  42 (14.3)
  22 (7.5)
    3 (1.1)
23 (31.5)
38 (52)
  6 (8.2)
  6 (8.2)
–
  43 (20.7)
120 (57.7)
  36 (17.3)
    8 (3.8)
    1 (0.5)
0.10
Convention, n (%)   54 (18.4) 20 (27.4)   41 (19.7) 0.22
Diagnosis, n (%)
  Chronic pain syndrome   24 (8.2)   7 (9.6)   26 (13.9) 0.27
  Fibromyalgia   43 (14.6) 16 (21.9)   42 (20.2) 0.15
  Polyalgia   66 (22.4) 14 (19.2)   47 (22.6) 0.98
  Rachialgia   54 (18.4) 13 (17.8)   41 (19.7) 0.90
  Headaches   29 (9.9)   4 (5.5)     9 (4.3) 0.05
  Osteoarthritis     6 (2)   0 (0)     1 (0.4) 0.17
  Mixed pain     6 (2)   1 (1.4)     7 (3.4) 0.52
  Neuropathic pain   26 (8.8)   7 (9.6)   21 (10) 0.89
  Visceral pain     8 (2.7)   3 (4.1)     5 (2.4) 0.74
  Other   57 (19.4) 15 (20.5)   31 (14.9) 0.35
  Not mentioned     8 (2.7)   3 (4.1)     1 (0.4) 0.09
Pain duration, months, median [IQR]     6 [3–13.25]   8 [5–13.25]     6 [3–13.75] 0.10
Therapist expertise, n (%)
  Therapist 1 (28 years)
  Therapist 2 (25 years)
  Therapist 3 (15 years)
  Therapist 4 (6 years)
106 (59.9)
  84 (48)
  47 (45.2)





  55 (31.1)
  61 (34.9)
  41 (39.4)
  51 (42.8)
0.04*
Randomization, n (%)  
  Randomized
  Non-randomized




  80 (38.5)
128 (61.5)
< 0.001*
Delay onset of treatment, months, median [IQR]     3 [2–4]   4 [2–5]    3 [2–4] < 0.001*
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IHLC and PHLC subscales of the MHLC, PCS 
subscale of the SF-36 and the disability, harm, emo-
tion, solicitude, medical cure and medication subscales 
of the SOPA-35 (p > 0.05) (Table II). Significant dif-
ferences were found for fatigue intensity (p = 0.02), 
showing less fatigue intensity for continuers 6.48 
(2.15) than for early 6.87 (2.4) and late 6.93 (2.14) 
drop-outs. The anxiety subscale of the HADS was also 
significant (p = 0.04): continuers showing less anxiety 
11.37 (4.19) compared with early 12.5 (4.22) and late 
12.12 (1.14) drop-outs. A significant effect was found 
for the MSC subscale of the SF-36 (p = 0.001), de-
monstrating that continuers had a better mental quality 
of life 29.60 (12.66) than early 25.7 (13.23) and late 
26.19 (12.18) drop-outs. Only the “perceived control” 
subscale of the SOPA-35 differed statistically across 
groups (p = 0.03), showing that early 5.9 (4.93) and 
late 6.59 (4.11) drop-outs had less perceived control 
than continuers 7.23 (4.06).
Multiple logistic regression analyses
An 8-predictor logistic model was fitted to the data to 
test the research hypothesis regarding the likelihood 
of dropping out of a pain management programme 
(Table III). Concerning late drop-outs, only the educa-
tional level was statistically significant: intermediate 
Table II. Mean and standard deviation (SD) or median and 1st and 3rd interquartile ranges (IQR) for non-normal distribution of the 18 
variables measured at baseline. Early drop-outs: patients who never started the treatments; late drop-outs: patients who attended to 







(n = 208) p-value
Pain intensity (NRS) (18) 6 [5–7] 6 [5–7] 6 [5–7] 0.22
Fatigue intensity (NRS) (19) 7 [5–8] 7 [6–9] 7 [6–8] 0.02*











Insomnia Severity Index (21) 17 [13–20] 19 [14.5–22] 18 [14–22] 0.08
Pain Disability Index (22) 38 [30–47] 41 [30.75–52.75] 42 [31–51] 0.09
Multidimensional Health Locus of Control (23)
  Chance Health Locus of Control (CHLC)
  Internal Health Locus of Control (IHLC)














  Physical quality of life (PCS)















  Medical Cure
  Medication











  9 [4–13]
12 [9–14]
14 [11–16]














*p-value < 0.05. NRS: numerical rating scale.
Table III. Results of multiple logistic regression analysis of potential predictors for drop-out (educational level, therapist expertise, 
randomization, delay onset of treatment, subscale anxiety of the Hospital Anxiety and Depression Scale (HADS), Mental quality of 
life (MCS) of the Short Form-36 (SF-36) and subscale control of the Survey of Pain Attitude-35 (SOPA-35)). Early drop-outs: patients 
who never started the treatments; late drop-outs: patients who attended < 6 sessions out of 9
Variables
Early drop-outs Late drop-outs
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value Global p-value
Educational level < 0.001*
  Intermediate vs low










  Therapist [2] vs therapist [1]
  Therapist [3] vs therapist [1]














  Randomized vs non-randomized 2.34 (1.22–4.46) 0.009* 1.16 (0.75–1.81) 0.49
Delay onset of treatment 1.25 (1.08–1.44) 0.007* 1.03 (0.92–1.14) 0.54 0.007*
Fatigue intensity (NRS) (19) 0.94 (0.81–1.09) 0.46 1.02 (0.92–1.12) 0.62 0.60
Anxiety (HADS) (20) 1.04 (0.96–1.12) 0.31 1.02 (0.96–1.07) 0.42 0.52
MCS (SF-36) (25) 0.99 (0.96–1.02) 0.74 0.99 (0.97–1.01) 0.53 0.81
Control (SOPA-35) (24) 0.91 (0.84–0.99) 0.03* 0.97 (0.93–1.02) 0.38 0.09
*p-value < 0.05. 95% CI: 95% confidence interval.
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educational level (p = 0.002) and high educational level 
(p = 0.005) protected against dropping out during treat-
ment. Regarding early drop-outs, educational level was 
a significant protector, but only for the intermediate level 
(p = 0.04). Delay in onset of treatment was significant 
(p = 0.001), meaning that a delay of more than 4 months 
increased the risk of not starting treatment. Randomiza-
tion was also statistically significant (p = 0.009), being 
randomized increased the risk of not starting treatment.
DISCUSSION 
The aim of this study was to identify the profile of 
patients committed to a biopsychosocial approach to 
pain management by considering type of drop-out. 
The objective was not to understand if the treatment’s 
efficacy would influence drop-out rates, but if a priori 
characteristics would have an impact. Univariate analy-
ses yielded 8 potential predictors of drop-out, out 
of 18 variables eligible for inclusion in multivariate 
logistic regression analyses. These analyses revealed 
an association between patients’ educational level and 
all types of drop-outs, showing that an intermediate or 
a high educational level protects against drop-out by 
0.6 (67%) and 0.6 (68%), for early and late drop-outs, 
respectively. Furthermore, an association was found 
between delay in onset of treatment and randomization 
for early drop-outs only. This means that a delay longer 
than or equal to 4 months increases the risk of never 
attending the first session of treatment by 0.02 (25%). 
The fact of being randomized in any of the treatment 
groups increases the risk of never attending the first 
session of treatment by approximately 134%. 
Given the scarcity of studies focusing on drop-out 
from chronic pain treatments and the similarities bet-
ween treatments for chronic pain and psychological 
disorder (e.g. anxiety and addiction), this discussion 
will sometimes rely on the literature regarding patients 
with psychological disorders. 
A recent meta-analysis highlighted that scientific 
liter ature about drop-out in chronic pain is controversial 
(5). Depending on the studies, associations between 
drop-out rates and various socio-demographics, such as 
age, sex, occupational status, convention and aetiologies, 
are conflicting, and do not allow us to consider them as 
real predictors (5). In the current study, none of these 
variables were significantly associated with drop-out, 
potentially because they display rather inconsistent as-
sociations with drop-out throughout the literature and 
are, consequently, not acknowledged as predictors of 
drop-out. Furthermore, to our knowledge, the SF-36 
subscales, SOPA-35 subscales and MHLC subscales, 
and PDI and ISI scores have not been investigated as 
potential predictors in other studies, making it difficult 
to compare the current results with other studies. Even 
though no statistical significance was found, drop-outs 
vs continuers had higher scores in anxiety (12.22 (4.15) 
vs 11.37 (4.19), respectively) and depression (10.2 (4.22) 
vs 9.55 (4.43), respectively), in the Insomine Severity 
Index (18.52 (8.56) vs 17.06 (6.81), respectively) and 
in the Pain Disability Index (40.27 (14.29) vs 38.12 
(13.14), respectively). Subscales of the SOPA-35 also 
differed slightly, but did not attain significance: drop-outs 
had higher scores in the harm subscale (10.09 (3.91)) vs 
continuers (9.8 (3.95)), in the emotion subscale (12.37 
(5.49)) vs continuers (11.78 (5.01)) and in the medical 
cure subscale (11.23 (3.42)) vs continuers (10.94 (3.22)). 
Drop-outs had lower scores for perceived control (6.41 
(3.98)) vs continuers (7.23 (4.06)) and solicitude (8.51 
(5.16)) vs continuers (9.19 (4.96)). From a clinical point 
of view, it is of interest to note that distressed patients 
may also be more likely not to complete the treatment.
Concerning socio-demographic factors, the results 
showed a significant association only for educational 
level and drop-out: drop-outs (early and late) with a 
low educational level tended either to never attend the 
first session, or to drop-out during treatment. However, 
other studies of drop-out predictors in chronic pain 
have shown that patients with a high educational level 
tend to be more likely to drop-out (10), or even that no 
link exists between education and drop-out (27). The 
results of a study by Oosterhaven et al. (9) were similar 
to the current results. Various studies have repeatedly 
demonstrated an association between poorer health 
outcomes and lower levels of education (28). One 
explanatory linkage is considered to be health literacy, 
i.e. “the cognitive and social skills which determine the 
motivation and ability of individuals to gain access to, 
understand and use information in ways which promote 
and maintain good health” (29). It has been shown that 
low education is correlated with low health literacy 
skills (28). Considering this definition, it seems logical 
to assume that low health literacy skills are a barrier to 
health information, healthcare access and lower health 
in general (28). Low health literacy was also associated 
with low self-reported mental health, low self-reported 
physical health and low self-reported general health in 
healthy subjects (28). In addition, patients with low 
health literacy had higher scores of pain intensity and 
pain perception (30). Others have reported that 54% of 
chronic pain patients (n = 131) had low health literacy, 
which was associated with low educational levels and 
less perceived controle over pain (31). Finally, and in 
agreement with the current results, Hardman et al. (32) 
showed that low health literacy, and thus low educa-
tion, was associated with higher rates of drop-out (32). 
As all treatments had self-management components, it 
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related to self-efficacy. This was not done in the current 
study, and therefore constitutes a limitation that should 
be addressed in future studies.
In the current study, the delay in onset of treat-
ments, also termed “waiting time” by other authors 
(15), increased the risk of never starting treatment by 
25%. One study, focusing on psychotherapy in sub-
stance abuse, showed that a prolonged delay in onset 
of treatment was associated with increased drop-out 
rates before the beginning of treatment (33) and after 
admission (34). A longer delay may generate second 
thoughts in entering the programme, alter treatment ex-
pectations, and reduce motivation to enter a treatment 
programme (15, 35). Unfortunately, delay in onset is 
often due to organizational factors, such as randomiza-
tion, as was the case in this study. In a similar way to 
that of centralized intake units for substance abuse, an 
alternative for chronic pain management could be to 
propose “treatment before the treatment”, to patients. 
This “pre-treatment” could be dedicated to explaining 
the mechanisms related to chronic pain, the biopsy-
chosocial model of chronic pain, and highlighting 
the active role that the patient needs to endorse in the 
management of pain.
The most notable result of this study is that being 
randomized in any of the treatment groups was as-
sociated with a greater likelihood of never starting 
treatment compared with non-randomized patients. 
Randomized control trials (RCT) are considered to be 
the “gold-standard” in evidence-based practice (36). 
Nevertheless, different limitations have been mentio-
ned concerning the application of RCTs in psychologi-
cal therapy (not specific to chronic pain management), 
one of which seems accurate within this framework: 
often, the patients have been referred due to informa-
tion about the reputation of the lead therapist, hence 
they are unlikely to be blind to the treatment options 
(36). It is reasonable to think that one might feel less 
involved if one is not in the treatment programme desir-
ed initially. Furthermore, patients who are included in 
the decision-making process regarding treatment seem 
to increase their personal involvement, which maxi-
mizes the treatment effect (37–39). In other words, 
allowing patients to choose their treatment might alter 
their subjective appraisal of the treatment, and, hence, 
the treatment outcome, in a more positive way. We 
propose that personalized medicine, pragmatic trials, 
and qualitative studies should be promoted in clinical 
research. The fact that patients do not complete the 
proposed treatment probably impacts the multidisci-
plinary team, possibly diminishing their motivation in 
providing state-of-the-art care. To our knowledge no 
study has investigated this issue, and future research 
on this topic would be of great interest.
Clinicians should enhance health literacy especially 
for those patients with low educational levels. By doing 
so, patients would eventually be able to understand 
their active role in the management of their pain, 
which would empower them and increase treatment 
adherence independently of the proposed treatment. 
Various communication skills aim at increasing 
patients’ motivation and decision-making (40). For 
example, motivational interviewing aims at allowing 
patients to address ambivalence about positive be-
havioural changes, making it especially interesting 
in the management of chronic pain, as the majority 
of treatments aim to change maladaptive behaviours 
into adaptive ones (40). Prospective studies assessing 
drop-out should also be conducted. This study was 
retrospective, and therefore could not take into account 
all potential predictors of drop-out.
In conclusion, this study emphasizes that drop-out 
might not be associated with patients’ characteristics 
(except for education), but rather with external factors 
inherent to the application of evidence-based prac-
tice. The results show that randomization increases 
the risk of never attending the treatment sessions. In 
order to overcome this deleterious effect, researchers 
should rely on pragmatic, quasi-experimental, and 
observation al trials, as well as qualitative studies to 
complement more classical RCTs. 
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